Abstract LB323: Inhibition of ENPP1 using small molecule, SR-8541A, enhances the effect of checkpoint inhibition in cancer models by Weston, Alexis S., Thode, Trason, Ng, Serina, Ghosh-Halder, Tithi, Rheinschmidt, Shelby, Adamson, Sydney, Gutowsky, Katelyn, Durbin, Brian, Soldi, Raffaella, Kasibhatla, Srinivas, Kaadige, Mohan, Sharma, Sunil

Get full text

Abstract 1666: Novel peptides target the β-catenin/TBL1 complex to competitively inhibit dysregulated Wnt signaling in cancer by Rheinschmidt, Shelby, Thode, Trason, Sampson, Samuel, Weston, Alexis, Halder, Tithi Ghosh, Ng, Serina, Adamson, Sydney, Gutowsky, Kate, Kaadige, Mohan, Soldi, Raffaella, Sharma, Sunil

Get full text

Abstract 2567: Targeting TBL1/β-catenin complex using peptides designed to competitively inhibit aberrant Wnt signaling in cancer by Rheinschmidt, Shelby, Thode, Trason, Sampson, Samuel, Weston, Alexis, Halder, Tithi Ghosh, Ng, Serina, Rodriguez del Villar, Ryan, Kaadige, Mohan, Zernov, Anton, Machluf, Marcelle, Soldi, Raffaella, Sharma, Sunil

Get full text

Abstract 4060: Selective Neoantigens Peptide TILs (snapTILs): A next generation tumor infiltrating lymphocytes (TIL) therapy platform by Halder, Tithi Ghosh, Rheinschmidt, Shelby, Adamson, Sydney, Larson, Anna, Bargenquast, Taylor, Rodriguez del Villar, Ryan, Ng, Serina, Gutowsky, Kate, Weston, Alexis, Thode, Trason, Kaadige, Mohan, Kelley, Erin, Soria-Bustos, Jorge, Giron, Jorge, Altin, John, Soldi, Raffaella, Sharma, Sunil

Get full text

Abstract 1069: A novel PAThway based RNA and DNA Integration with Tumor Organoid Testing (PATRIOTTM) platform predicts therapeutic options in cohorts with MET overexpression and CD... by Larson, Anna, Bargenquast, Taylor, Byron, Sara, Raju, Anish, Podder, Avijit, Rheinschmidt, Shelby, Halder, Tithi Ghosh, Sampson, Samuel, Adamson, Sydney, Ng, Serina, Gutowsky, Kate, Weston, Alexis, Thode, Trason, Moser, Justin, Borazanci, Erkut, Kaadige, Mohan, Schork, Nicholas, Soldi, Raffaella, Sharma, Sunil

Get full text

Abstract 2688: Inhibition of CDK7 using small molecule inhibitor, TGN-1062, augments the effect of cisplatin treatment in head and neck PDX models by Thode, Trason, Weston, Alexis, Ng, Serina, Rheinschmidt, Shelby, Halder, Tithi Ghosh, Adamson, Sydney, Gutowsky, Kate, Durbin, Brian, Soldi, Raffaella, Kaadige, Mohan, Kasibhatla, Srinivas, Han, Haiyong, Moser, Justin, Chung, Vincent, Chao, Joseph, Villaflor, Victoria, Von Hoff, Daniel D., Sharma, Sunil

Get full text

Abstract 3931: TGN-1062 inhibits CDK7 and augments the effects of gemcitabine and nab-paclitaxel in pancreatic cancer models by Weston, Alexis, Thode, Trason, Rodriguez del Villar, Ryan, Ng, Serina, Sampson, Samuel, Rheinschmidt, Shelby, Halder, Tithi Ghosh, Soldi, Raffaella, Kaadige, Mohan, Kasibhatla, Srinivas, Han, Haiyong, Moser, Justin, Chung, Vincent, Chao, Joseph, Villaflor, Victoria, Von Hoff, Daniel, Sharma, Sunil

Get full text

Abstract 1878: 3D Tumor models in drug discovery for high throughput analysis of immune cell infiltration by Halder, Tithi Ghosh, Rheinschmidt, Shelby, Thode, Trason, Sampson, Samuel, Rodriguez del Villar, Ryan, Ng, Serina, Weston, Alexis, Kaadige, Mohan, Trent, Jeffery, Altin, John, Moser, Justin, Borazanci, Erkut, Gordon, Michael, Larson, Anna, Soldi, Raffaella, Sharma, Sunil

Get full text

Abstract 1048: Synergistic drug combination of LSD1 and ABL2 inhibitors for Ewing's sarcoma identified in an arrayed CRISPR screen approach by Sampson, Samuel, Thode, Trason, Drenner, Kevin, Del Villar, Ryan Rodriguez, Ozols, Annika, Kaadige, Mohan, Weston, Alexis, Ng, Serina, Halder, Tithi Ghosh, Rheinschmidt, Shelby, Anderson, David, Holden, Kevin, Soldi, Raffaella, Sharma, Sunil

Get full text